Analyst Ratings for Teva Pharmaceutical Industries Ltd. ADR (TEVA)Updated: 2017-07-28
Teva Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, TEVA was issued an average rating of Overweight.
9 analysts declared TEVA a buy, 3 issued an overweight rating, 14 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. During this time, the number of analysts bearish on the stock has decreased by 1.
TEVA was given price targets by several analysts. The maximum price target given was 50, implying potential capital gains of 54.08 percent. The most pessimistic price target was 28, which equates to a potential downside of -13.71 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -4.05 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -3.54 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.12 percent. If we look at the last 90 days instead, we find a net average change of 0 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 4 analysts made negative revisions. Over the same time period, 2 analysts revised their FY earnings estimates upwards, while 2 analysts decreased their estimates.
TEVA has an estimated earnings growth rate of 3553.38 percent as forecasted by analysts. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of TEVA is 0.07.
TEVA has a 52-week high of 55.79 and a 52-week low of 27.60. The current market price is above the trailing year's low by 17.57 percent, and below the high by 41.84 percent. TEVA has a P/E ratio of 253.91. Investors typically compare the P/E ratio to a company's peers in the industry. The TEVA value stock report compares TEVA to some of its peers using value stock charts. The market cap of TEVA is $33.27 billion. TEVA will post this quarters earnings in days, on 0000-00-00.